Do complications following pancreatic resections impact hospital costs in France: Medico-economic study on 127 patients - 03/12/18
, M. Fulbert a, b, X. Lenne b, c, G. Clément b, c, E. Drumez b, d, F.-R. Pruvot a, b, S. Truant a, bBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Objective |
To define the cost of pancreatectomies and to identify factors associated with increased hospital costs after pancreatic resection.
Methods |
All patients undergoing pancreatic surgery in our department between January 2008 and December 2014 were included. All complications occurring during hospitalization or in the 90-day period after discharge were documented. The hospital costs were analyzed and predictive factors of increased hospital costs were determined.
Results |
One hundred and twenty seven patients were identified. Most patients underwent pancreatectomy for malignant tumors (70%). Median hospital costs were 21,392 [15,998–29,667] euros. Age (P=0.011) and preoperative jaundice (P<0.001) were associated with higher hospital costs. Intraoperative surgical time and blood loss were correlated with increased costs (P=0.001 and P=0.002, respectively). Pancreatoduodenectomy was associated with statistically significantly higher costs compared to distal pancreatectomy (21,770 vs. 15,422 euros, P=0.001). Severe postoperative complications (Clavien-Dindo grade≥3) (P=0.001), septic complications (P=0.002) and hemorrhage (P=0.001) statistically significantly increased costs. In multivariate analysis, septic (P=0.003) and severe complications (P=0.01) were statistically significantly associated with increased hospital costs.
Conclusion |
Pancreatic surgery is associated with high hospital costs, essentially related to postoperative complications.
Le texte complet de cet article est disponible en PDF.Keywords : Pancreatectomy, Cost, Morbidity, Mortality, Postoperative complications
Plan
Vol 155 - N° 6
P. 465-470 - décembre 2018 Retour au numéro
Article précédent
- Esophagectomy in patients with liver cirrhosis: a systematic review and Bayesian meta-analysis
- E. Asti, M. Sozzi, G. Bonitta, D. Bernardi, L. Bonavina
- Treatment of polycystic liver disease. Update on the management
- B. Aussilhou, S. Dokmak, F. Dondero, D. Joly, F. Durand, O. Soubrane, J. Belghiti
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?